L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medicatio…
- Recall date
- March 5, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0417-2025
- FDA classification
- Class II
- Brand / firm
- L'Oreal USA
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
Get recall alerts
Free email alert whenever L'Oreal USA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: L'Oreal USA